Artiva Biotherapeutics, Inc. Common Stock (ARTV)

9.97

(-9.69%)

EBITDA Summary of Artiva Biotherapeutics, Inc. Common Stock

  • Artiva Biotherapeutics, Inc. Common Stock's latest annual EBITDA in 2023 was -28.4 Million USD , up 50.38% from previous year.
  • Artiva Biotherapeutics, Inc. Common Stock's latest quarterly EBITDA in 2024 Q1 was -13.63 Million USD , down -22.23% from previous quarter.
  • Artiva Biotherapeutics, Inc. Common Stock reported an annual EBITDA of -58.67 Million USD in 2022, up 18.03% from previous year.
  • Artiva Biotherapeutics, Inc. Common Stock reported an annual EBITDA of -71.57 Million USD in 2021, down -303.96% from previous year.
  • Artiva Biotherapeutics, Inc. Common Stock reported a quarterly EBITDA of -13.63 Million USD for 2024 Q1, down -22.23% from previous quarter.
  • Artiva Biotherapeutics, Inc. Common Stock reported a quarterly EBITDA of N/A for 2023 FY, up 50.38% from previous quarter.

Annual EBITDA Chart of Artiva Biotherapeutics, Inc. Common Stock (2023 - 2020)

Historical Annual EBITDA of Artiva Biotherapeutics, Inc. Common Stock (2023 - 2020)

Year EBITDA EBITDA Growth
2023 -28.4 Million USD 50.38%
2022 -58.67 Million USD 18.03%
2021 -71.57 Million USD -303.96%
2020 -17.71 Million USD 0.0%

Peer EBITDA Comparison of Artiva Biotherapeutics, Inc. Common Stock

Name EBITDA EBITDA Difference